FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine, particularly to ophthalmology. Substance of the invention consists in the fact that a pharmaceutical composition for preventing a proliferative cell-mediated response, containing Mytomycin C, sodium chloride and water for injections, additionally comprises microcrystalline cellulose as a gelling material. The composition is suggested for prevention the proliferative cell-mediated response in surgical management of glaucoma, pterygium, and refractive surgeries.
EFFECT: composition reduces the toxic effect of the preparation Mytomycin C on the tissues adjacent to an operative site, prevents the deterioration of an expected surgical outcome, and reduces the length of the patients' rehabilitation period.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR RECURRENT PTERYGIUM PREVENTION | 2016 |
|
RU2646125C1 |
| METHOD FOR SURGICAL TREATMENT OF GLAUCOMA | 2004 |
|
RU2281073C2 |
| METHOD OF SURGICAL TREATMENT OF GLAUCAMA DEVELOPED AGAINST THE BACKGROUND OF IRIDOCORIAL ENDOTHELIAL SYNDROME | 2018 |
|
RU2675967C1 |
| METHOD FOR TREATING PATIENTS SUFFERING FROM A COMBINATION OF GLAUCOMA AND CATARACT | 1996 |
|
RU2143250C1 |
| METHOD FOR TREATING CHILDREN AND YOUNG PATIENTS FOR GLAUCOMA | 2006 |
|
RU2313317C1 |
| METHOD FOR SCLERAL CAVITY SCARRING PREVENTION IN ANTIGLAUCOMATOUS OPERATIONS | 2009 |
|
RU2400192C1 |
| REFRACTORY GLAUCOMA SURGERY | 2008 |
|
RU2367395C1 |
| SURGICAL METHOD FOR TREATING GLAUCOMA | 2000 |
|
RU2196555C2 |
| CORNEA NEOVASCULARISATION AGGRESSIVE APPROACH | 2008 |
|
RU2369364C1 |
| METHOD FOR SURGICAL TREATMENT OF OPEN-ANGLE GLAUCOMA | 2016 |
|
RU2630884C1 |
